Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases

被引：10

作者：

Hartley, James Leon ^{[1
]}

Bailey, Neil ^{[2
]}

Sharma, Asheesh ^{[3
]}

Shawki, Howida ^{[4
]}

机构：

[1] Royal Liverpool Univ Hosp, Nephrol, Liverpool, Merseyside, England

[2] Warrington & Halton Teaching Hosp NHS Fdn Trust, Nephrol, Warrington, Cheshire, England

[3] Royal Liverpool & Broadgreen Hosp NHS Trust, Nephrol, Liverpool, Merseyside, England

[4] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Histopathol, Liverpool, Merseyside, England

来源：

BMJ CASE REPORTS | 2022年 / 15卷 / 03期

关键词：

COVID-19; immunological products and vaccines; renal system; vaccination; immunisation; nephrotic syndrome;

D O I：

10.1136/bcr-2021-244638

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present two cases of nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine. We discuss the initial presentation, investigation and management of these patients along with a discussion around the current evidence base for vaccine-induced nephrotic syndrome.

引用

下载

页数：5

共 50 条

[1] Minimal Change Nephrotic Syndrome with Acute Kidney Injury after the Administration of Pfizer-BioNTech COVID-19 Vaccine
Gulumsek, Erdinc
Ozturk, Dilan Damla
Ozturk, Huseyin Ali
Saler, Tayyibe
Erdogan, Kivilcim Eren
Bashir, Ahmed Muhammad
Sumbul, Hilmi Erdem
CASE REPORTS IN INFECTIOUS DISEASES, 2023, 2023
[2] Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
Lebedev, Larissa
Sapojnikov, Marina
Wechsler, Alexander
Varadi-Levi, Ronen
Zamir, Doron
Tobar, Ana
Levin-Iaina, Nomy
Fytlovich, Shlomo
Yagil, Yoram
AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (01) : 142 - 145
[3] Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
Komaba, Hirotaka
Wada, Takehiko
Fukagawa, Masafumi
AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (03) : 469 - 470
[4] Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination
Kobayashi, Seiji
Fugo, Kazunori
Yamazaki, Kazuto
Terawaki, Hiroyuki
CLINICAL KIDNEY JOURNAL, 2021, 14 (12) : 2606 - 2607
[5] Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine
Tanaka, Fumika
Katayama, Kan
Joh, Kensuke
Tsujimoto, Kayo
Yamawaki, Masahiro
Saiki, Ryosuke
Kurita, Tairo
Murata, Tomohiro
Dohi, Kaoru
CLINICAL KIDNEY JOURNAL, 2022, 15 (03) : 567 - 568
[6] An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
Maas, Rutger J.
Gianotten, Sanne
van der Meijden, Wilbert A. G.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (02) : 312 - 312
[7] Minimal Change Disease After First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Review of Minimal Change Disease Related to COVID-19 Vaccine
Hanna, Jessica
Ingram, Alistair
Shao, Tiffany
CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2021, 8
[8] Pfizer-BioNTech COVID-19 Vaccine
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1642): : 16 - 16
[9] Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
D'Agati, Vivette D.
Kudose, Satoru
Bomback, Andrew S.
Adamidis, Ananea
Tartini, Albert
KIDNEY INTERNATIONAL, 2021, 100 (02) : 461 - 463
[10] Minimal change nephrotic syndrome four days after the administration of Pfizer-BioNTech COVID-19 vaccine-a new side effect or coincidence?
Abdulgayoom, Mohammed
Albuni, Mhd Kutaiba
Abdelmahmuod, Elabbass
Murshed, Khaled
Eldeeb, Yassir
CLINICAL CASE REPORTS, 2021, 9 (10):

← 1 2 3 4 5 →